Several recent studies have shown an increased expression of TMED3 in a number of cancers and TMED3 promotes the carcinogenesis of liver, breast, colorectal, lung, and endometrial cancer as well as glioma and osteosarcoma [61,62,63,64,65,66,67]. This evidence concerns the gene TMED3 and osteosarcoma.